Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Am J Gastroenterol. 2022 Dec 23;118(7):1214–1225. doi: 10.14309/ajg.0000000000002125

Figure 2: Status of Patients from Week 192 (Eligible for Withdrawal) to Week 240 (End of Follow-up).

Figure 2:

Of 188 participants reaching week 192, 111 qualified and were initially withdrawn from TDF treatment: 53% in the TDF group and 65% in the combination group. However, 9 (5 in the TDF group and 4 in the combination group) were placed back on treatment because of protocol changes for safety. Of the 102 participants who met the modified protocol criteria for withdrawal of TDF, 12 (5 of 56 in the combination group and 7 of 46 in the TDF group) restarted TDF before week 240 due to relapse.